Society of Nuclear Medicine

Type: Organization

Name: Society of Nuclear Medicine

First reported May 21 2013 - Updated May 22 2013 - 1 reports

MILabs introduces Vector+ SPECT/PET system

-- Preclinical imaging technology developer MILabs has debuted Vector+, the next generation of its Vector SPECT/PET molecular imaging system.Vector+ offers several new exchangeable collimators and the option to choose thicker crystals for more counts, ... [Published AuntMinnieEurope - May 21 2013]

Entities: Vector, Society of Nuclear Medicine, Molecular Imaging Corp, Molecular Imaging

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Syntermed gets 510(k) for nuclear cardiac software

-- Imaging software developer Syntermed has been awarded 510(k) clearance from the U.S. Food and Drug Administration for its Emory Cardiac Toolbox version 4.0 nuclear cardiac software.To view the remainder of this article, and other exclusive content, ... [Published Aunt Minnie - May 20 2013]

Entities: Nuclear, Society of Nuclear Medicine, Molecular Imaging Corp, perfusion

First reported May 17 2013 - Updated May 17 2013 - 2 reports

AREVA Group

AREVA Med LLC Med Presents Pharmacokinetics Data From Phase 1 Clinical Trial at SNMMI

Staying up-to-date has never been simpler. Sign up for the today! BETHESDA, Md., May 17, 2013 (GLOBE NEWSWIRE) -- AREVA Med, an AREVA subsidiary specializing in the development of new innovative therapies to fight cancer, announced today that it will ... [Published BioSpace - May 17 2013]

Entities: AREVA Group, Pharmacokinetics, Phase I, Clinical trials

First reported May 16 2013 - Updated May 17 2013 - 2 reports

FDA Food & Drug Administration

SNMMI Applauds FDA Approval of Radium-223 Dichloride (Xofigo)

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) commends the U.S. Food and Drug Administration (FDA) for its approval of radium-223 dichloride (Xofigo) for the treatment of patients with castration-resistant prostate cancer (CRPC), symptomatic ... [Published US Society of Nuclear Medicine - May 17 2013]

Entities: Radium-223, FDA Food & Drug Administration, bone metastases, Metastatic

First reported May 11 2013 - Updated May 11 2013 - 1 reports

Rick Perry

Gov. Perry names Beasley chair of Texas Board of Licensure for Professional Medical Physicists

AUSTIN – Gov. Rick Perry has named Charles W. Beasley of Bellaire chair of the Texas Board of Licensure for Professional Medical Physicists, and has appointed three members to the board for terms to expire Feb. 1, 2019. The board regulates the practice ... [Published Cleveland Advocate - May 11 2013]

Entities: Rick Perry, American College of Radiology, Society of Nuclear Medicine, Medical Physics, Radiology

First reported May 11 2013 - Updated May 11 2013 - 1 reports

National Cancer Institute

SNMMI Holds Joint Workshop with the National Cancer Institute on Targeted Radionuclide Therapy

Reston, Va.– Leading experts and stakeholders concerned with the advancement of targeted radionuclide therapy joined together in March at the National Institutes of Health campus in Bethesda, Md., for a joint workshop held by the National Cancer Institute ... [Published US Society of Nuclear Medicine - May 11 2013]

Entities: Radionuclide, National Cancer Institute, Society of Nuclear Medicine, Molecular Imaging Corp, Molecular Imaging

First reported May 10 2013 - Updated May 10 2013 - 1 reports

Society of Nuclear Medicine

Research Study performed at Phoebe to be presented in Vancouver

Phoebe Putney Memorial Hospital has taken great strides in research studies and in June, Sam Belakhlef, MD, will present the results of a recent study at this year’s Society of Nuclear Medicine and Molecular Imaging meeting. The largest international ... [Published WFXL - May 10 2013]

Entities: Vancouver, Society of Nuclear Medicine, Molecular Imaging Corp

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Navidea deploying MSLs in launch of new diagnostic agent

Navidea Biopharmaceuticals is launching Lymphoseek, its diagnostic agent used to check for cancer spread, with a mix of medical affairs, promotional education and CME aimed at the nuclear medicine community.The injection, green-lighted by FDA in March, ... [Published Medical Marketing And Media - May 02 2013]

Entities: Navidea Biopharmaceuticals Inc, Diagnostic, lymphatic mapping, Lymphoseek

First reported May 01 2013 - Updated May 01 2013 - 1 reports

Inflammatory Bowel Disease Detection Enhanced with PET/CT

Reston, Va. – Inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis, may be detected and monitored more effectively in the future with positron emission tomography/computed tomography (PET/CT), according to research published ... [Published US Society of Nuclear Medicine - May 01 2013]

Entities: Positron Emission Tomography, Inflammatory Bowel Disease, University of Münster

First reported Apr 22 2013 - Updated Apr 22 2013 - 1 reports

Continuing the Conversation about "Choosing Wisely"

On February 21, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) released a list of "Five Things Physicians and Patients Should Question" in nuclear medicine and molecular imaging as part of the Choosing Wisely® campaign, led by the ABIM ... [Published Advance for Imaging & Radiation Oncology - Apr 22 2013]

Entities: Nuclear Medicine, Thyroid, Society of Nuclear Medicine, Molecular Imaging Corp, Molecular Imaging

First reported Jan 28 2013 - Updated Jan 29 2013 - 1 reports

First guidelines for brain amyloid imaging may aid Alzheimer’s diagnosis

Washington, January 28 : The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimer's Association have jointly published the first criteria for the appropriate use of positron emission tomography(PET) to aid in the diagnosis of people ... [Published Topnews.in - Jan 28 2013]

Entities: Alzheimer's Disease, Positron Emission Tomography, Alzheimer's Association

Quotes

..." says Frederik Beekman, Founder and CEO of MILabs. "I am very excited to now announce the VECTor+, with significant improvements in performance. With better spatial resolution and sensitivity, VECTor+ will truly enable in-depth biological studies that have never been possible before."

VECTor+ promises dramatic improvements in SPECT/PET technology [Published MedicalPhysicsWeb - May 22 2013]

...was awarded 510(k) clearance recently for Emory Cardiac Toolbox(TM) version 4.0 creating a game changing environment for nuclear cardiac labs. "One of the many things that makes Emory Toolbox 4.0 different is SmartReport, the first-ever, cloud-based nuclear cardiology reporting tool using decision support" said Michael Lee, CEO, Syntermed, Inc...

Syntermed Awarded 510(k) Clearance for Novel Cardiac Imaging Decision Support System - Emory Tool ... [Published Zecco - May 20 2013]

...to three ovarian cancer patients with abdominal metastasis," said Ruby Meredith, M D , Principal Investigator at University of Alabama Birmingham. "To date, 212Pb-TCMC-Trastuzumab has been well tolerated with no serious adverse events."

AREVA Med Presents Pharmacokinetics Data From Phase 1 Clinical Trial at SNMMI [Published OSIX News - May 17 2013]

"It's novel in the clinic because it's the only therapeutic radiopharmaceutical we have that is an alpha emitter" Frederic H Fahey, DSc, president of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), told DOTmed News

FDA approves radiopharmaceutical to treat advanced prostate cancer [Published Dotmed - May 16 2013]

More Content

sort by: Date \| Relevance
VECTor+ promises dramatic improvements in SPECT... [Published MedicalPhysicsWeb - May 22 2013]
MILabs introduces Vector+ SPECT/PET system [Published AuntMinnieEurope - May 21 2013]
Targeted Radioisotope Therapy Extends Life for ... [Published MolecularImaging.net - May 21 2013]
PERCIST: PET Interpretation Improved [Published MolecularImaging.net - May 21 2013]
Syntermed gets 510(k) for nuclear cardiac software [Published Aunt Minnie - May 20 2013]
Amyvid makers call for CMS coverage of amyloid ... [Published MolecularImaging.net - May 20 2013]
Syntermed Awarded 510(k) Clearance for Novel Ca... [Published Zecco - May 20 2013]
AREVA Med LLC Med Presents Pharmacokinetics Dat... [Published BioSpace - May 17 2013]
AREVA Med LLC Med Presents Pharmacokinetics Dat... [Published BioSpace - May 17 2013]
AREVA Med Presents Pharmacokinetics Data From P... [Published OSIX News - May 17 2013]
SNMMI Applauds FDA Approval of Radium-223 Dichl... [Published US Society of Nuclear Medicine - May 17 2013]
FDA approves radiopharmaceutical to treat advan... [Published Dotmed - May 16 2013]
Gov. Perry names Beasley chair of Texas Board o... [Published Cleveland Advocate - May 11 2013]
SNMMI Holds Joint Workshop with the National Ca... [Published US Society of Nuclear Medicine - May 11 2013]
NIS Cardiac PET with MiE Scintron Receives FDA ... [Published Dotmed - May 10 2013]
Research Study performed at Phoebe to be presen... [Published WFXL - May 10 2013]
Immunomedics Announces Third Quarter Fiscal 201... [Published Individual.com - May 08 2013]
Immunomedics Announces Third Quarter Fiscal 201... [Published Morningstar.com - May 08 2013]
PERCIST’s Potential: PET & Quantification [Published MolecularImaging.net - May 03 2013]
Navidea deploying MSLs in launch of new diagnos... [Published Medical Marketing And Media - May 02 2013]
SNMMI Treks North to Vancouver [Published MolecularImaging.net - May 02 2013]
A dirty trick by Malacañang on voters [Published Philippine Daily Inquirer - May 02 2013]
Navidea Biopharmaceuticals' CEO Hosts Lymphosee... [Published Seeking Alpha - May 02 2013]
Lantheus Medical Imaging to Proceed with Flurpi... [Published BioMedReports - May 01 2013]
Inflammatory Bowel Disease Detection Enhanced w... [Published US Society of Nuclear Medicine - May 01 2013]
Lantheus to present data on PET cardiac imaging... [Published MedicalPhysicsWeb - Apr 30 2013]
Lantheus Medical Imaging to Present Data on Nov... [Published BioMedReports - Apr 29 2013]
Lantheus Medical Imaging to Present Data on Nov... [Published Business Wire - Apr 29 2013]
Continuing the Conversation about "Choosing Wis... [Published Advance for Imaging & Radiation Oncology - Apr 22 2013]
Blaze Bioscience Announces Two Poster Presentat... [Published Yahoo! Finance - Feb 27 2013]